New Jersey’s life sciences sector is poised for continued growth in 2024, following a year in which the industry was a key source of demand for commercial real estate owners.
Market experts say large, high-profile office deals are likely still to come in New Jersey, despite the push for hybrid schedules and lingering questions about the return to work.
